Targeted therapy represents a significant advancement in cancer treatment. These drugs specifically target cancer cells while sparing normal cells, thereby reducing side effects. Examples include HER2 inhibitors for breast cancer and EGFR inhibitors for lung cancer. The efficacy of these treatments often depends on the presence of specific biomarkers, which can be identified through genetic testing.
